Cargando…

Blocking indolamine 2,3 dioxygenase mediated rebound immune suppression improves systemic anti-tumor effects of radio-immunotherapy

Detalles Bibliográficos
Autores principales:	Monjazeb, Arta M, Kent, Michael, Grossenbacher, Steven K, Murphy, William
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649418/ http://dx.doi.org/10.1186/2051-1426-3-S2-P368

Ejemplares similares

Combined radiotherapy and immunotherapy using CPG oligodeoxynucleotides and indolamine 2,3 dioxygenase (IDO) blockade
por: Monjazeb, Arta M, et al.
Publicado: (2013)

Enhanced natural killer cell targeting of cancer stem cells using Cetuximab
por: Grossenbacher, Steven K, et al.
Publicado: (2014)

Combination radioimmunotherapy with adoptive NK transfer targets cancer stem cells in canine models of bone and soft tissue sarcoma
por: Canter, Robert, et al.
Publicado: (2015)

Macrophages/Microglia Represent the Major Source of Indolamine 2,3-Dioxygenase Expression in Melanoma Metastases of the Brain
por: Herrera-Rios, Dayana, et al.
Publicado: (2020)

Bystander memory CD8 T cell proliferation after anti-CD40/IL-2 treatment is independent of CD4 T cells
por: Grossenbacher, Steven K, et al.
Publicado: (2013)

Need to focus on inhibitory activity of benzimidazole analogues against indolamine 2,3-dioxygenase-1 (IDO-1)
por: Sharma, Akshansh, et al.
Publicado: (2022)

Indoleamine 2,3-dioxygenase is a critical resistance mechanism in anti-tumor T cell immunotherapy targeting CTLA-4
por: Holmgaard, Rikke B, et al.
Publicado: (2013)

Limited Effect of Indolamine 2,3-Dioxygenase Expression and Enzymatic Activity on Lupus-Like Disease in B6.Nba2 Mice
por: Davison, Laura M., et al.
Publicado: (2019)

Immunoediting and Antigen Loss: Overcoming the Achilles Heel of Immunotherapy with Antigen Non-Specific Therapies
por: Monjazeb, Arta Monir, et al.
Publicado: (2013)

Indoleamine-2,3-dioxygenase activity induces neutrophil apoptosis
por: Van der Sluijs, K, et al.
Publicado: (2011)

Curcumin combined with FAPαc vaccine elicits effective antitumor response by targeting indolamine-2,3-dioxygenase and inhibiting EMT induced by TNF-α in melanoma
por: Jiang, Guan-Min, et al.
Publicado: (2015)

Butyrate Produced by Commensal Bacteria Down-Regulates Indolamine 2,3-Dioxygenase 1 (IDO-1) Expression via a Dual Mechanism in Human Intestinal Epithelial Cells
por: Martin-Gallausiaux, Camille, et al.
Publicado: (2018)

Combined Inhibition of Indolamine-2,3-Dioxygenase 1 and C-X-C Chemokine Receptor Type 2 Exerts Antitumor Effects in a Preclinical Model of Cervical Cancer
por: Lizcano-Meneses, Solangy, et al.
Publicado: (2023)

Respiratory syncytial virus replication induces Indoleamine 2,3-dioxygenase (IDO) activation in human dendritic cells
por: Ajamian, Farnam, et al.
Publicado: (2010)

Preclinical assessment of a novel small molecule inhibitor of indoleamine 2,3-dioxygenase 1 (IDO1)
por: Driessens, Gregory, et al.
Publicado: (2014)

Preclinical assessment of a novel small molecule inhibitor of tryptophan 2,3-dioxygenase 2 (TDO2)
por: Crosignani, Stefano, et al.
Publicado: (2014)

Melanoma-derived Wnt5a conditions dendritic cells to promote regulatory T cell differentiation via the upregulation of indoleamine 2,3-dioxygenase: novel pharmacological strategies for augmenting immunotherapy efficacy
por: Zhao, Fei, et al.
Publicado: (2014)

Expression of indoleamine 2.3-dioxygenase by tumors induces local and systemic immunosuppressive effects in a murine melanoma model
por: Holmgaard, Rikke B, et al.
Publicado: (2014)

Editorial: Targeting Indoleamine 2,3-dioxygenases and Tryptophan Dioxygenase for Cancer Immunotherapy
por: Brochez, Lieve, et al.
Publicado: (2021)

Endotoxin-Induced Tryptophan Degradation along the Kynurenine Pathway: The Role of Indolamine 2,3-Dioxygenase and Aryl Hydrocarbon Receptor-Mediated Immunosuppressive Effects in Endotoxin Tolerance and Cancer and Its Implications for Immunoparalysis
por: Wirthgen, Elisa, et al.
Publicado: (2015)

P16-52. HIV-activated human plasmacytoid DCs induce Tregs through an indoleamine 2,3-dioxygenase-dependent mechanism
por: Manches, O, et al.
Publicado: (2009)

Melatonin: A Novel Indolamine in Oral Health and Disease
por: Chava, V. K., et al.
Publicado: (2012)

Monoclonal antibody therapies targeting immune checkpoints induce fatal anaphylactic reactions in a murine model of breast cancer
por: Mall, Christine, et al.
Publicado: (2014)

Bortezomib sensitizes human glioblastoma stem cells to adoptive natural killer cell cytotoxicity
por: Grossenbacher, Steven, et al.
Publicado: (2015)

Resonance of coefficient of variation induced by rebound currents for stochastic inhibitory inputs
por: Dodla, Ramana, et al.
Publicado: (2007)

On-line identification of the end of motor imageries based on the alpha rebound detection
por: Lindig-León, Cecilia, et al.
Publicado: (2015)

Probiotics Differently Affect Gut-Associated Lymphoid Tissue Indolamine-2,3-Dioxygenase mRNA and Cerebrospinal Fluid Neopterin Levels in Antiretroviral-Treated HIV-1 Infected Patients: A Pilot Study
por: Scagnolari, Carolina, et al.
Publicado: (2016)

Indoleamine 2,3-dioxygenase-1 (IDO1) expression by childhood acute myeloid leukemias inhibits T-cell production of IFN-γ and confers an unfavorable prognosis
por: Rutella, Sergio, et al.
Publicado: (2013)

Bystander Activation and Anti-Tumor Effects of CD8+ T Cells Following Interleukin-2 Based Immunotherapy Is Independent of CD4+ T Cell Help
por: Monjazeb, Arta M., et al.
Publicado: (2014)

Long-lasting disease stabilization in the absence of toxicity in metastatic lung cancer patients vaccinated with an HLA-A2-restricted epitope derived from indoleamine 2,3 dioxygenase
por: Iversen, Trine Z, et al.
Publicado: (2013)

Nanomedicine and cancer immunotherapy: focus on indoleamine 2,3-dioxygenase inhibitors
por: Zulfiqar, Bilal, et al.
Publicado: (2017)

Therapeutic hypothermia in cardiac arrest survivors: is rebound hyperthermia a significant issue with intravascular cooling?
por: Price, T, et al.
Publicado: (2015)

The Obesity Paradox in Cancer, Tumor Immunology, and Immunotherapy: Potential Therapeutic Implications in Triple Negative Breast Cancer
por: Naik, Adviti, et al.
Publicado: (2019)

Tumor hypoxia drives immune suppression and immunotherapy resistance
por: Ai, Midan, et al.
Publicado: (2015)

Rebound hypotension following terlipressin bolus infusion can be prevented by continuous low-dose infusion of terlipressin
por: Lange, M, et al.
Publicado: (2007)

Tumor-induced suppressive CD8+ T cells: implications for cancer immunotherapy
por: Pfannenstiel, Lukas W, et al.
Publicado: (2013)

Mouse Preclinical Cancer Immunotherapy Modeling Involving Anti-PD-1 Therapies Reveals the Need to Use Mouse Reagents to Mirror Clinical Paradigms
por: Monjazeb, Arta M., et al.
Publicado: (2021)

Indoleamine-2,3-Dioxygenase 1 Deficiency Suppresses Seizures in Epilepsy
por: Deng, Ning, et al.
Publicado: (2021)

CTL-mediated immunotherapy can suppress SHIV rebound in ART-free macaques
por: Fan, Jin, et al.
Publicado: (2019)

Anti-proliferative but not anti-angiogenic tyrosine kinase inhibitors enrich for cancer stem cells in soft tissue sarcoma
por: Canter, Robert J, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_31aqua8tn1q3nepdtm1he2ot9r